Press releases

Month Year

Email alerts

Jun 30, 2011

Medtronic Announces U.S. Launch of New Inflatable Bone Tamp and Syringe System for Treatment of Vertebral Compression Fractures

Kyphon Xpander(TM) II Inflatable Bone Tamp and the Kyphon(R) Inflation Syringe are Latest Innovation in Minimally Invasive Treatment of Spinal Fractures

MEMPHIS, Tenn., Jun 30, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation...
Jun 29, 2011

Medtronic Commends Congress and the Institute of Medicine on Study on Advancing Pain Research, Care and Education

MINNEAPOLIS, Jun 29, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of...
Jun 28, 2011

Medtronic Introduces an Innovative Mobile Application for the CareLink(R) Network

The CareLink(TM) Mobile Application Offers Direct Mobile Access to Data on the Medtronic CareLink(R) Network

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care...
Jun 28, 2011

Medtronic CEO Omar Ishrak Statement on rhBMP-2 Articles in Spine Journal

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant...
Jun 25, 2011

Research Presented at ADA Adds to the Clinical Evidence for Medtronic's Sensor-Augmented Insulin Pump Therapy

STAR 3 Continuation Data, Low Glucose Suspend and Patient Reported Outcomes Highlighted at American Diabetes Association's 71st Scientific Sessions

SAN DIEGO, Jun 25, 2011 (BUSINESS WIRE) -- Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's...

Show per page